A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition

被引:469
作者
Malhotra, AK
Kestler, LJ
Mazzanti, C
Bates, JA
Goldberg, T
Goldman, D
机构
[1] Hillside Hosp, Unit Mol Psychiat, Glen Oaks, NY 11004 USA
[2] NIAAA, Neurogenet Lab, Rockville, MD 20852 USA
关键词
D O I
10.1176/appi.ajp.159.4.652
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: In the prefrontal cortex, the enzyme catechol O-methyltransferase (COMT) is critical in the metabolic degradation of dopamine, a neurotransmitter hypothesized to influence human cognitive function. The COMT gene contains a functional polymorphism, Val158Met, that exerts a fourfold effect on enzyme activity. The current study investigated whether prefrontal cognition varies with COMT genotype. Method: Val158Met was genotyped in 73 healthy volunteers. A task of prefrontal cognition, the Wisconsin Card Sorting Test, was also administered. Results: Subjects with only the low-activity met allele made Significantly fewer perseverative errors on the Wisconsin Card Sorting Test than did subjects with the val allele. Conclusions: These data are consistent with those of previous studies, suggesting that a functional genetic polymorphism may influence prefrontal cognition.
引用
收藏
页码:652 / 654
页数:3
相关论文
共 12 条
[1]  
Allison DB, 1997, AM J HUM GENET, V60, P676
[2]   Cognition and control in schizophrenia: A computational model of dopamine and prefrontal function [J].
Braver, TS ;
Barch, DM ;
Cohen, JD .
BIOLOGICAL PSYCHIATRY, 1999, 46 (03) :312-328
[3]   Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia [J].
Egan, MF ;
Goldberg, TE ;
Kolachana, BS ;
Callicott, JH ;
Mazzanti, CM ;
Straub, RE ;
Goldman, D ;
Weinberger, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (12) :6917-6922
[4]   Cognitive improvement during tolcapone treatment in Parkinson's disease [J].
Gasparini, M ;
Fabrizio, E ;
Bonifati, V ;
Meco, G .
JOURNAL OF NEURAL TRANSMISSION, 1997, 104 (8-9) :887-894
[5]  
Heaton R.K., 1981, MANUAL WISCONSIN CAR
[6]   Subchronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat [J].
Jentsch, JD ;
Tran, A ;
Le, D ;
Youngren, KD ;
Roth, RH .
NEUROPSYCHOPHARMACOLOGY, 1997, 17 (02) :92-99
[7]   3-METHOXYTYRAMINE IS THE MAJOR METABOLITE OF RELEASED DOPAMINE IN THE RAT FRONTAL-CORTEX - REASSESSMENT OF THE EFFECTS OF ANTIPSYCHOTICS ON THE DYNAMICS OF DOPAMINE RELEASE AND METABOLISM IN THE FRONTAL-CORTEX, NUCLEUS-ACCUMBENS, AND STRIATUM BY A SIMPLE 2-POOL MODEL [J].
KAROUM, F ;
CHRAPUSTA, SJ ;
EGAN, MF .
JOURNAL OF NEUROCHEMISTRY, 1994, 63 (03) :972-979
[8]  
KNEAVEL M, 2000, SOC NEUROSCI, V26, P1535
[9]   Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders [J].
Lachman, HM ;
Papolos, DF ;
Saito, T ;
Yu, YM ;
Szumlanski, CL ;
Weinshilboum, RM .
PHARMACOGENETICS, 1996, 6 (03) :243-250
[10]   Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11 [J].
Li, T ;
Ball, D ;
Zhao, J ;
Murray, RM ;
Liu, X ;
Sham, PC ;
Collier, DA .
MOLECULAR PSYCHIATRY, 2000, 5 (01) :77-84